Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WW domain containing E3 ubiquitin protein ligase 1 pseudogene 1 (WWP1P1) is a human gene classified as a pseudogene. It is so named because its sequence closely resembles that of the protein-coding gene WWP1, which encodes an E3 ubiquitin ligase involved in ubiquitination, transcription regulation, cell signaling, and is associated with diseases and cancer[1][4][5]. Unlike the functional WWP1, WWP1P1 does not have documented protein-coding potential or physiological or pathological function. Therefore, it is not a recognized therapeutic target, does not code for a receptor, enzyme, or other molecular entity of biomedical interest, and no drugs are described to interact with it[1][4][5]. As a pseudogene, WWP1P1 may exist as noncoding DNA whose remnants serve as evolutionary or regulatory artifacts but not as an active biological entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WW domain containing E3 ubiquitin protein ligase 1 pseudogene 1 (WWP1P1).